Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

ClinicalTrials.gov ID: NCT01289015

Public ClinicalTrials.gov record NCT01289015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with tinea pedis.

Study identification

NCT ID
NCT01289015
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merz North America, Inc.
Industry
Enrollment
855 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Oct 31, 2011
Completion
Dec 31, 2011
Last update posted
Sep 25, 2013

2011 – 2012

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Associated Foot & Ankle Specialists, LLC Phoenix Arizona 85015
Skin Surgery Medical Group, Inc. San Diego California 92117
UCSF Dermatology Research San Francisco California 94115
The Savin Center, PC New Haven Connecticut 06511
Avail Clinical Research DeLand Florida 32720
Jacksonville Center for Clinical Research Jacksonville Florida 32216
International Dermatology Research, Inc. Miami Florida 33144
Miami Dermatology Research Institute, LLC North Miami Beach Florida 33162
Radiant Research, Inc. Pinellas Park Florida 33781
Northwest Clinical Trials Boise Idaho 83704
Physician Skin Care Louisville Kentucky 40217
Michigan Center for Skin Care Research Clinton Township Michigan 48038
Henry Ford Hospital Detroit Michigan 48202
Minnesota Clinical Study Center Fridley Minnesota 55432-3133
Skin Search of Rochester, Inc. Rochester New York 14623
Crescent Medical Research Salisbury North Carolina 28144
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Paddington Testing Co., Inc. Philadelphia Pennsylvania 19103
Tennessee Clinical Research Center Nashville Tennessee 37215
DermResearch, Inc. Austin Texas 78759
The Center for Skin Research Houston Texas 77056
Endeavor Clinical Trials, PA San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01289015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2013 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01289015 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →